References
- DohánODe La ViejaAParoderVThe sodium/iodide symporter (NIS): characterization, regulation, and medical significanceEndocr Rev2003241487712588808
- AhnB-CSodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and backTheranostics20122439240222539935
- OhJMKalimuthuSGangadaranPReverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene systemOncotarget2018967075708729467951
- LeeYLLeeYJAhnSJCombined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFPCancer Lett2010290112913819819065
- SeidlinSMMarinelliLDOshryERadioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroidCA Cancer J Clin19904052993172118414
- KimJEHwangMHLeeHWLeeSWLeeJAhnBCCombined RNA interference of adenine nucleotide translocase-2 and ganciclovir therapy in hepatocellular carcinomaNucl Med Biol201340898799324054501
- GangadaranPRajendranRLLeeHWExtracellular vesicles from mesenchymal stem cells activates VEGF receptors and accelerates recovery of hindlimb ischemiaJ Control Release201726411212628837823
- GangadaranPHongCMAhnB-CAn Update on in Vivo Imaging of Extracellular Vesicles as Drug Delivery VehiclesFront Pharmacol2018916929541030
- GangadaranPHongCMAhnB-CCurrent perspectives on in vivo noninvasive tracking of extracellular vesicles with molecular imagingBiomed Res Int201720178111
- EkenCGasserOZenhaeusernGOehriIHessCSchifferliJAPoly-morphonuclear neutrophil-derived ectosomes interfere with the matu-ration of monocyte-derived dendritic cellsJ Immunol2008180281782418178820
- GasserOHessCMiotSDeonCSanchezJ-CSchifferliJAChar-acterisation and properties of ectosomes released by human polymor-phonuclear neutrophilsExp Cell Res2003285224325712706119
- LöscheWScholzTTemmlerUOberleVClausRAPlatelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophilsPlatelets200415210911515154603
- PluskotaEWoodyNMSzpakDExpression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived mic-roparticlesBlood200811262327233518509085
- ZhuLOhJMGangadaranPTargeting and therapy of glioblastoma in a mouse model using exosomes derived from natural killer cellsFront Immunol2018982429740437
- GangadaranPLiXJLeeHWA new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in miceOncotarget201786610989410991429299117
- ChungJ-KSodium iodide symporter: its role in nuclear medicineJ Nucl Med20024391188120012215558
- HouPBojdaniEXingMInduction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathwaysJ Clin Endocrinol Metab201095282082820008023
- ChakravartyDSantosERyderMSmall-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activationJ Clin Invest2011121124700471122105174
- ChengLJinYLiuMRuanMChenLHER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600EOncotarget2017812198431985428423638
- KelkarMGSenthilkumarKJadhavSGuptaSAhnBCDeAEnhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulationSci Rep201661934126777440
- LiuZXingMInduction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cellsPLoS One201272e3172922359623
- RuanMLiuMDongQChenLIodide- and glucose-handling gene expression regulated by sorafenib or cabozantinib in papillary thyroid cancerJ Clin Endocrinol Metab201510051771177925768669
- CabanillasMEPatelADanyshBPDaduRKopetzSFalchookGBRAF inhibitors: experience in thyroid cancer and general review of toxicityHorm Cancer201561213625467940
- DaduRDevineCHernandezMRole of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenibJ Clin Endocrinol Metab20149962086209424628550
- MiyazakiTIkedaKSatoWHorie-InoueKInoueSExtracellular vesicle-mediated EBAG9 transfer from cancer cells to tumor microenvironment promotes immune escape and tumor progressionOncogenesis201871729362448
- SettiMOstiDRichichiCExtracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growthOncotarget2015631314133142726429879
- ArturiFRussoDSchlumbergerMIodide symporter gene expression in human thyroid tumorsJ Clin Endocrinol Metab1998837249324969661633
- ChatterjeeSThakerNDeACombined 2-deoxy glucose and metfor-min improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cellsBreast Cancer2015725126526355636
- JangSCKimOYYoonCMBioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumorsACS Nano2013797698771024004438
- WuJYJiALWangZXExosome-Mimetic Nanovesicles from hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivoSci Rep201881247129410409
- GangadaranPHongCMOhJMIn vivo Non-invasive Imaging of Radio-Labeled Exosome-Mimetics Derived From Red Blood Cells in MiceFront Pharmacol2018981730104975
- KalimuthuSGangadaranPRajendranRLA new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapyFront Pharmacol20189111630319428
- GunassekaranGRHongC-MVadevooSMPNon-genetic engineering of cytotoxic T cells to target IL-4 receptor enhances tumor homing and therapeutic efficacy against melanomaBiomaterials201815916117329329051